Register Now for The Outlook on Active Nutrition
News|Articles|March 19, 2026

Samriddh’s B-Lit Bacopa Demonstrates Clinical Efficacy for Stress Reduction and Sleep Quality in New Research

Author(s)Erin McEvoy
Listen
0:00 / 0:00

Key Takeaways

  • A 12-week RCT in 50 adults showed perceived stress reduction by week two and progressive sleep-quality gains from week three versus placebo, reaching markedly larger effects by week 12.
  • Actigraphy indicated total sleep time increased 27.6 minutes with B-Lit Bacopa while placebo decreased 5.52 minutes, aligning objective sleep improvement with subjective reports.
SHOW MORE

The randomized placebo-controlled trial showed Samriddh’s Bacopa monnieri extract significantly improved perceived stress, sleep quality, and cortisol levels in adults with non-chronic stress.

Samriddh Nutractive Pvt. Ltd. has announced new clinical data supporting the efficacy of its branded B-Lit Bacopa (Bacopa monnieri) extract for stress management and sleep quality. The findings come from a randomized, double-blind, placebo-controlled trial. B-Lit Bacopa is standardized to 30% total bacosides and utilizes Samriddh’s proprietary Bio Enhanced Active Technology (BEAT Tech), designed to improve bioavailability and absorption, a March 11 press release from the company explains.1

Clinical Study: Stress, Mood, and Sleep

Published in Current Research in Complementary & Alternative Medicine in February 2026, the study, “Efficacy and Safety of Bacopa monnieri Extract for Stress Management and Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Trial,” examined the effects and tolerability of the adaptogen.2 The 12-week study evaluated 50 healthy adults experiencing non-chronic stress, who were randomized to receive either B-Lit Bacopa or a placebo once daily. Researchers assessed a range of endpoints, including perceived stress, sleep quality, mood state, anxiety, serum cortisol levels, and objective sleep parameters measured via wrist actigraphy.

Results: Improvements Across Outcomes

According to the results, supplementation with B-Lit Bacopa led to statistically significant improvements across multiple outcomes. Participants in the active group experienced reductions in perceived stress as early as two weeks, compared to placebo. Sleep quality improvements were observed by week three and continued to increase throughout the study duration, with reported benefits reaching up to seven times greater than placebo by week 12.

In addition to improvements in subjective sleep measures, objective sleep also improved. Total sleep time increased by an average of 27.6 minutes in the B-Lit Bacopa group, while the placebo group saw a decrease of 5.52 minutes.

Serum cortisol was also included as a biomarker of physiological stress, specifically for the hypothalamic-pituitary-adrenal (HPA) axis. Bacopa monnieri is believed to help regulate the HPA axis, the study explains. Participants receiving B-Lit Bacopa demonstrated a significant reduction in cortisol levels, with an average decrease of 4.10 µg/dL. In contrast, the placebo group showed a slight increase.

The study also reported favorable safety outcomes, with no significant adverse effects observed, reinforcing the ingredient’s suitability for use in dietary supplements targeting stress and sleep support. “This randomized, double-blind, placebo-controlled study further validates B-Lit Bacopa for managing everyday stress and improving sleep quality,” stated Aditya Jain, Founder and CEO of Samriddh. “The significant reductions in perceived stress and cortisol levels, along with improvements in sleep quality and duration, highlight B-Lit Bacopa as a safe and effective solution for supporting emotional wellness and restorative sleep in today’s high-stress environment.”

Previous Clinical Research on Memory

These new findings build on previous clinical research conducted on B-Lit Bacopa, which demonstrated significant cognitive benefits,3 including improvements in memory domains such as short-term, working, and spatial memory, as well as enhancements in alertness and mental flexibility. Notably, this earlier data also showed increases in serum brain-derived neurotrophic factor (BDNF), suggesting potential neuroprotective effects. Anxiety and cortisol levels were also significantly reduced.

Published in 2024 in the Journal of Psychiatry and Cognitive Behaviour, “Effect of Bacopa monnieri Extract on Memory and Cognitive Skills in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Study” involved 80 healthy participants who received either 300 mg of the extract or a placebo daily for 12 weeks.4 No safety concerns were observed throughout the study, and the extract was well tolerated.

This article was created with assistance from AI. The content has been reviewed and edited by Erin McEvoy, Associate Editor. For more information on the extent and nature of AI usage, please contact us.

References

  1. Samriddh Reveals 2nd Clinical Study with B-Lit Bacopa for Stress Management and Sleep Quality. Press released provided via email March 11, 2026. Accessed March 19, 2026.
  2. Gowda SS, Joshua L, Thomas JV. Efficacy and Safety of Bacopa monnieri Extract for Stress Management and Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Trial. Curr Res Cmpl Alt Med. 2026;10(280). doi: 10.29011/2577-2201.100280
  3. Krawiec S. Proprietary Bacopa extract sees significant improvements in memory and cognition in recent study. Published April 4, 2026. Accessed March 19, 2026. https://www.nutritionaloutlook.com/view/proprietary-bacopa-extract-sees-significant-improvements-in-memory-and-cognition-in-recent-study
  4. Eraiah MM, Shekhar HC, Joshua L, Thomas JV. Effect of Bacopa monnieri Extract on Memory and Cognitive Skills in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Study. J Psychiatry Cogn Behav. 2024;8(168). doi: 10.29011/2574-7762.000068